News for ARS Pharmaceuticals Inc Stock (SPRY)

Investigation Into ARS Pharmaceuticals Inc Initiated By The Schall Law Firm Encouraging Impacted Investors To Begin Dialogue

Accesswire • 07/12/24

ARS Pharmaceuticals Inc Under Investigation By The Schall Law Firm Urging Affected Investors To Initiate Conversation

Accesswire • 07/11/24

The Schall Law Firm Initiates Inquiry Into ARS Pharmaceuticals Inc And Encourages Impacted Investors To Start Dialogue

Accesswire • 07/10/24

The Schall Law Firm Starts Investigation Into ARS Pharmaceuticals Inc And Urges Affected Investors To Begin Interaction

Accesswire • 07/09/24

The Schall Law Firm Initiates Probe Into ARS Pharmaceuticals Inc And Encourages Impacted Investors To Start Interaction

Accesswire • 07/08/24

The Schall Law Firm Starts Scrutiny Of Allegations Against ARS Pharmaceuticals Inc And Promotes Investors With Losses To Take Part

Accesswire • 07/07/24

Investigation Into ARS Pharmaceuticals Inc Is Launched By The Schall Law Firm And It Motivates Affected Investors To Engage

Accesswire • 07/06/24

The Schall Law Firm Initiates Examination Into Accusations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Participate

Accesswire • 07/05/24

The Schall Law Firm Commences Inquiry Into Allegations Against ARS Pharmaceuticals Inc And Urges Affected Investors To Get Involved

Accesswire • 07/03/24

Probe Into Claims Against ARS Pharmaceuticals Inc Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Participate

Accesswire • 07/02/24

The Schall Law Firm Initiates Probe Into Claims Against ARS Pharmaceuticals Inc And Urges Affected Investors To Participate

Accesswire • 06/28/24

ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)

GlobeNewsWire • 06/28/24

The Schall Law Firm Begins Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved

Accesswire • 06/27/24

The Schall Law Firm Begins Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Join

Accesswire • 06/25/24

The Schall Law Firm Starts Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved

Accesswire • 06/23/24

The Schall Law Firm Begins Probe Into Claims Against ARS Pharmaceuticals Inc And Urges Affected Investors To Participate

Accesswire • 06/22/24

The Schall Law Firm Initiates Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved

Accesswire • 06/21/24

Allegations Against ARS Pharmaceuticals Inc Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved

Accesswire • 06/19/24

Allegations Against ARS Pharmaceuticals Inc The Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved

Accesswire • 06/18/24

Claims Against Ars Pharmaceuticals Inc Schall Law Firm Begins Probe And Urges Affected Investors To Participate

Accesswire • 06/17/24

Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved

Accesswire • 06/11/24

Charges Against ARS Pharmaceuticals, Inc.: Schall Law Firm Launches Examination And Invites Affected Investors To Participate

Accesswire • 06/09/24

Accusations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Inquiry And Calls On Impacted Investors To Engage

Accesswire • 06/08/24

Claims Against ARS Pharmaceuticals, Inc.: Schall Law Firm Begins Probe And Invites Affected Investors To Connect

Accesswire • 06/07/24

Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Reach Out

Accesswire • 06/06/24